What Are The Risk Factors For Dynavax Technologies Corporation (DVAX)?


As of Friday close, Dynavax Technologies Corporation’s (NASDAQ:DVAX) stock was down -$0.34, moving down -3.48 percent to $9.44. The average number of shares traded per day over the past five days has been 2,282,900 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.29 fall in that time frame. In the last twenty days, the average volume was 1,941,170, while in the previous 50 days, it was 1,563,962.

Since last month, DVAX stock retreated -17.55%. Shares of the company fell to $9.42 on 03/17/23, the lowest level in the past month. A 52-week high of $17.48 was reached on 02/03/23 after having rallying from a 52-week low of $7.26. Since the beginning of this year, DVAX’s stock price has dropped by -11.28% or -$1.20, and marked a new high 10 times. However, the stock has declined by -46.00% since its 52-week high.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


DVAX stock investors should be aware that Dynavax Technologies Corporation (DVAX) stock had its last reported insider trading activity 19 days ago on Feb 27. Burgess Justin, the Chief Accounting Officer of the company, disposed of 22,371 shares for $10.38 on Feb 27. It resulted in a $232,146 divestment by the insider. Hack Andrew A. F. sold 1,500,000 shares at an average price of $11.60 on Dec 06. The insider now owns 3,915,000 shares following the transaction. On Nov 08, President & COO Novack David F sold 52,204 shares at $12.47 apiece. The transaction was valued at $650,984.

Valuation Metrics

Right now, Dynavax Technologies Corporation (DVAX) has a P/E ratio of about 4.86. The stock’s beta is 1.50. Besides these, the trailing price-to-sales (P/S) ratio of 1.70, the price-to-book (PB) ratio of 2.07, and the price-to-cash flow ratio of 22.03 may also be considered.

Financial Health

In the three months ended December 30, Dynavax Technologies Corporation’s quick ratio stood at 5.70, while its current ratio was 6.10, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending December 30 was 0.38, and the total debt-to-equity ratio was 0.38. On the profitability front, the trailing twelve-month gross margin is 63.70% percent. In the year ended December 30, operating margins totaled 39.20%. Based on annual data, DVAX earned $460.53 million in gross profit and brought in $722.68 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 35.20%. Return on equity (ROE) for the past 12 months was 65.40%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. DVAX’s revenue fell -5.73% to $167.74 million during the quarter, while net income inched up to $184.49 million. While analysts expected Dynavax Technologies Corporation to report $0.43 quarterly earnings, the actual figure was $0.45 per share, beating the consensus estimate by 4.70%. During the quarter, the company generated $62.37 million in EBITDA. The liabilities of Dynavax Technologies Corporation were 404.84 million at the end of its most recent quarter ended December 30, and its total debt was $258.01 million. The value of shareholders’ equity is $127.69 million.

Technical Picture

This quick technical analysis looks at Dynavax Technologies Corporation’s (DVAX) price momentum. With a historical volatility rate of 22.02%, the RSI 9-day stood at 24.40% on 17 March.

With respect to its five-day moving average, the current Dynavax Technologies Corporation price is down by -2.98% percent or -$0.29. At present, DVAX shares trade -15.11% below its 20-day simple moving average and -14.10% percent below its 100-day simple moving average. However, the stock is currently trading approximately -10.69% below its SMA50 and -20.40% below its SMA200.

Stochastic coefficient K was 14.00% and Stochastic coefficient D was 19.21%, while ATR was 0.33. Given the Stochastic reading of 1.79% for the 14-day period, the RSI (14) reading has been calculated as 28.49%. As of today, the MACD Oscillator reading stands at -0.16, while the 14-day reading stands at -0.32.


Please enter your comment!
Please enter your name here